Kidney Dysfunction and the Risk of Developing Aortic Stenosis.

[1]  H. Crijns,et al.  Calcific aortic valve stenosis: hard disease in the heart , 2017, European heart journal.

[2]  M. Vervloet,et al.  Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population. , 2017, The lancet. Diabetes & endocrinology.

[3]  Peter Kotanko,et al.  Inflammation and premature aging in advanced chronic kidney disease. , 2017, American journal of physiology. Renal physiology.

[4]  Joseph A. Sivak,et al.  Prevalence and Outcomes of Left‐Sided Valvular Heart Disease Associated With Chronic Kidney Disease , 2017, Journal of the American Heart Association.

[5]  Jeroen J. Bax,et al.  2017 ESC/EACTS Guidelines for the management of valvular heart disease. , 2017, European heart journal.

[6]  S. Larsson,et al.  Alcohol consumption, cigarette smoking and incidence of aortic valve stenosis , 2017, Journal of internal medicine.

[7]  M. Dweck,et al.  End stage renal disease‐induced hypercalcemia may promote aortic valve calcification via Annexin VI enrichment of valve interstitial cell derived‐matrix vesicles , 2017, Journal of cellular physiology.

[8]  S. Larsson,et al.  Overall and abdominal obesity and incident aortic valve stenosis: two prospective cohort studies , 2017, European heart journal.

[9]  J. Coresh,et al.  Prevalence and recognition of chronic kidney disease in Stockholm healthcare. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  H. Brenner,et al.  CKD Prevalence Varies across the European General Population. , 2016, Journal of the American Society of Nephrology : JASN.

[11]  Hyuk-Jae Chang,et al.  Effect of End-Stage Renal Disease on Rate of Progression of Aortic Stenosis. , 2016, The American journal of cardiology.

[12]  Marie Evans,et al.  The Stockholm CREAtinine Measurements (SCREAM) project: protocol overview and regional representativeness , 2015, Clinical kidney journal.

[13]  M. Woodward,et al.  Kidney measures beyond traditional risk factors for cardiovascular prediction: A collaborative meta-analysis , 2015, The lancet. Diabetes & endocrinology.

[14]  M. Budoff,et al.  Relation of aortic valve calcium to chronic kidney disease (from the Chronic Renal Insufficiency Cohort Study). , 2015, The American journal of cardiology.

[15]  Vilmundur Gudnason,et al.  Association of low-density lipoprotein cholesterol-related genetic variants with aortic valve calcium and incident aortic stenosis. , 2014, JAMA.

[16]  C. Giachelli,et al.  A current understanding of vascular calcification in CKD. , 2014, American journal of physiology. Renal physiology.

[17]  M. Budoff,et al.  Serum phosphate is associated with aortic valve calcification in the Multi-ethnic Study of Atherosclerosis (MESA). , 2014, Atherosclerosis.

[18]  Kathleen F. Kerr,et al.  Genetic associations with valvular calcification and aortic stenosis. , 2013, The New England journal of medicine.

[19]  Jennifer Taylor,et al.  ESC/EACTS Guidelines on the management of valvular heart disease. , 2012, European heart journal.

[20]  H. Schirmer,et al.  The evolving epidemiology of valvular aortic stenosis. The Tromsø Study , 2012, Heart.

[21]  Bertram L Kasiske,et al.  The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. , 2011, Kidney international.

[22]  J. Ludvigsson,et al.  External review and validation of the Swedish national inpatient register , 2011, BMC public health.

[23]  R. Cury,et al.  Associations of long-term and early adult atherosclerosis risk factors with aortic and mitral valve calcium. , 2010, Journal of the American College of Cardiology.

[24]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[25]  W. Paulus,et al.  Aortic stenosis , 2009, The Lancet.

[26]  B. Kestenbaum,et al.  Association of serum phosphate with vascular and valvular calcification in moderate CKD. , 2009, Journal of the American Society of Nephrology : JASN.

[27]  M. Budoff,et al.  Kidney function and aortic valve and mitral annular calcification in the Multi-Ethnic Study of Atherosclerosis (MESA). , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[28]  P. Li,et al.  Cardiac valvular calcification as a marker of atherosclerosis and arterial calcification in end-stage renal disease. , 2005, Archives of internal medicine.

[29]  V. Perkovic,et al.  Accelerated Progression of Calcific Aortic Stenosis in Dialysis Patients , 2003, Nephron Clinical Practice.

[30]  Sílvia Ribeiro,et al.  Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[31]  Catherine M. Otto,et al.  Clinical Factors Associated With Calcific Aortic Valve Disease , 1997 .

[32]  E. Maher,et al.  AORTIC AND MITRAL VALVE CALCIFICATION IN PATIENTS WITH END-STAGE RENAL DISEASE , 1987, The Lancet.

[33]  R. Lariviere,et al.  Association of interleukin-6 with aortic stiffness in end-stage renal disease. , 2018, Journal of the American Society of Hypertension : JASH.

[34]  K. Sakakura,et al.  Determinants of progression of aortic valve stenosis and outcome of adverse events in hemodialysis patients. , 2012, Journal of cardiology.

[35]  D. Levy,et al.  Cross-sectional association of kidney function with valvular and annular calcification: the Framingham heart study. , 2006, Journal of the American Society of Nephrology : JASN.

[36]  P. Ureña,et al.  Evolutive aortic stenosis in hemodialysis patients: analysis of risk factors. , 1999, Nephrologie.